Physician profile
Cecelia T Yu
NPI 1558467415
$2,939.28
in general payments reported to CMS, 2019-2025
34 companies · $429 in 2025
The $429 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,110 · 2020: $48.96 · 2021: $48.38 · 2022: $484 · 2023: $375 · 2024: $444 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,247.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $674.83 | 2019 | |
| Astellas Pharma US INC | $285.51 | 2019-2025 | Veozah |
| Abbvie INC. | $243.96 | 2019-2025 | Lo Loestrin Fe |
| Pfizer INC. | $217.54 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $141.29 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $115.04 | 2023-2025 | |
| Shield Therapeutics INC | $105.16 | 2023-2025 | Accrufer |
| Merck Sharp & Dohme LLC | $95.23 | 2019-2024 | Gardasil 9, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $88.07 | 2019-2025 | |
| Mylan Pharmaceuticals INC. | $83.78 | 2019-2022 | |
| Sage Therapeutics, LLC | $79.24 | 2025 | Zurzuvae |
| Myovant Sciences INC. | $76.41 | 2022 | |
| Minerva Surgical, INC | $75.90 | 2024 | |
| Organon LLC | $67.30 | 2022-2023 | Nexplanon |
| Aspira Women'S Health INC | $51.36 | 2023 | Ova1 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $50.43 | 2023-2024 | Slynd |
| Coopersurgical, INC. | $47.07 | 2024-2025 | Endosee, Paragard T 380a |
| Therapeuticsmd, INC. | $44.48 | 2019-2022 | |
| Hologic Sales and Service, LLC | $42.18 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Ethicon US, LLC | $38.01 | 2019 | |
| Agile Therapeutics, INC. | $37.92 | 2022 | |
| Allergan, INC. | $37.10 | 2019 | |
| Evofem Biosciences, INC. | $36.98 | 2022-2025 | Solosec, Phexx, Phexxi |
| Roche Diagnostics Corporation | $29.07 | 2019 | |
| Lupin INC. | $27.71 | 2019 | |
| Janssen Scientific Affairs, LLC | $22.89 | 2022 | |
| Amag Pharmaceuticals, INC. | $21.14 | 2019 | |
| Medtronic, INC. | $19.62 | 2025 | V-Loc 180 |
| Scynexis, INC. | $19.34 | 2022 | |
| Amgen INC. | $15.52 | 2024 | Prolia, Evenity |
| Becton, Dickinson and Company | $13.72 | 2019 | |
| Dysis Medical, INC. | $12.20 | 2019 | |
| Channel Medsystems, INC. | $11.90 | 2022 | |
| Avion Pharmaceuticals | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cecelia Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.